Summary:
Miami Dade Medical Research Institute is conducting a multinational randomized, double blind placebo controlled trial to evaluate the effect of an investigational product twice daily on the incidence
of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus.
Qualified Participants Must:
• Be over 50 years of age
•
Have been diagnosed with Type 2 Diabetes
•
Be at risk of Cardiovascular Events
such as angina, stent placement or by pass but without medical
history of heart attack
or myocardial infarction
.
Qualified Participants May Receive:
Stipend for time and transportation reimbursement
.